Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetaminophen and Fluvastatin for Zoledronic Acid Infusion Symptoms
NCT00145275Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of acetaminophen, fluvastatin in infusion-related reaction (IRR), sponsored by Novartis. Started Dec 2004; status: completed.
02
Drugs
acetaminophenfluvastatin
03
Conditions
infusion-related reaction (IRR)
Beyond the preview
Go deeper on NCT00145275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00145275.